Published in Alzheimer Dis Assoc Disord on August 19, 2015
Recruiting to preclinical Alzheimer's disease clinical trials through registries. Alzheimers Dement (N Y) (2017) 0.75
Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology (1993) 14.54
Disclosure of APOE genotype for risk of Alzheimer's disease. N Engl J Med (2009) 6.43
Testing the right target and right drug at the right stage. Sci Transl Med (2011) 3.55
Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease. Alzheimers Res Ther (2011) 2.51
Alzheimer's prevention initiative: a proposal to evaluate presymptomatic treatments as quickly as possible. Biomark Med (2010) 2.17
Subjective cognitive decline: self and informant comparisons. Alzheimers Dement (2013) 1.29
The neuropsychology of normal aging and preclinical Alzheimer's disease. Alzheimers Dement (2013) 1.09
Public perceptions of presymptomatic testing for Alzheimer disease. Mayo Clin Proc (2014) 0.93
Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect. N Engl J Med (2009) 4.45
HER2 and chromosome 17 effect on patient outcome in the N9831 adjuvant trastuzumab trial. J Clin Oncol (2010) 2.49
Impact of PTEN protein expression on benefit from adjuvant trastuzumab in early-stage human epidermal growth factor receptor 2-positive breast cancer in the North Central Cancer Treatment Group N9831 trial. J Clin Oncol (2013) 2.15
Integrating patient-reported outcomes into cancer symptom management clinical trials supported by the National Cancer Institute-sponsored clinical trials networks. J Clin Oncol (2007) 1.98
Predictability of adjuvant trastuzumab benefit in N9831 patients using the ASCO/CAP HER2-positivity criteria. J Natl Cancer Inst (2011) 1.94
The Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF): international prospective validation and reliability trial in 402 patients. Blood (2011) 1.93
Essential elements of genetic cancer risk assessment, counseling, and testing: updated recommendations of the National Society of Genetic Counselors. J Genet Couns (2011) 1.92
Radiotherapy and adjuvant trastuzumab in operable breast cancer: tolerability and adverse event data from the NCCTG Phase III Trial N9831. J Clin Oncol (2009) 1.80
Phase III trial of gabapentin alone or in conjunction with an antidepressant in the management of hot flashes in women who have inadequate control with an antidepressant alone: NCCTG N03C5. J Clin Oncol (2006) 1.68
Distinctive pulmonary histopathology with increased IgG4-positive plasma cells in patients with autoimmune pancreatitis: report of 6 and 12 cases with similar histopathology. Am J Surg Pathol (2009) 1.68
Scientific imperatives, clinical implications, and theoretical underpinnings for the investigation of the relationship between genetic variables and patient-reported quality-of-life outcomes. Qual Life Res (2010) 1.61
Quality of life after breast cancer surgery: What have we learned and where should we go next? J Surg Oncol (2009) 1.60
Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score: prospective international assessment of an abbreviated symptom burden scoring system among patients with MPNs. J Clin Oncol (2012) 1.58
Depressive symptoms in healthy apolipoprotein E ε4 carriers and noncarriers: a longitudinal study. J Clin Psychiatry (2013) 1.41
Reevaluating the imaging definition of tumor progression: perfusion MRI quantifies recurrent glioblastoma tumor fraction, pseudoprogression, and radiation necrosis to predict survival. Neuro Oncol (2012) 1.37
Immunohistochemistry and fluorescence in situ hybridization assessment of HER2 in clinical trials of adjuvant therapy for breast cancer (NCCTG N9831, BCIRG 006, and BCIRG 005). Breast Cancer Res Treat (2013) 1.34
Transoral laser microsurgery followed by radiation therapy for oropharyngeal tumors: the Mayo Clinic Arizona experience. Head Neck (2013) 1.26
Triple-negative breast cancers: unique clinical presentations and outcomes. Ann Surg Oncol (2010) 1.21
A literature synthesis of symptom prevalence and severity in persons receiving active cancer treatment. Support Care Cancer (2013) 1.21
C-MYC alterations and association with patient outcome in early-stage HER2-positive breast cancer from the north central cancer treatment group N9831 adjuvant trastuzumab trial. J Clin Oncol (2011) 1.21
Increase in contralateral prophylactic mastectomy: echoes of a bygone era? Surgical trends for unilateral breast cancer. Ann Surg Oncol (2010) 1.20
When research seems like clinical care: a qualitative study of the communication of individual cancer genetic research results. BMC Med Ethics (2008) 1.13
Pretransplant risk score for new-onset diabetes after kidney transplantation. Diabetes Care (2011) 1.13
Central pathology laboratory review of HER2 and ER in early breast cancer: an ALTTO trial [BIG 2-06/NCCTG N063D (Alliance)] ring study. Breast Cancer Res Treat (2014) 1.08
Androgen receptor-positive triple negative breast cancer: a unique breast cancer subtype. Ann Surg Oncol (2013) 1.07
Malignant melanoma in the elderly: different regional disease and poorer prognosis. J Cancer (2011) 1.06
Analysis and interpretation of results based on patient-reported outcomes. Value Health (2007) 1.04
The establishment of the GENEQOL consortium to investigate the genetic disposition of patient-reported quality-of-life outcomes. Twin Res Hum Genet (2009) 1.03
Position statement on the provision and procurement of human eggs for stem cell research. Cell Stem Cell (2013) 1.02
Longitudinal modeling of cognitive aging and the TOMM40 effect. Alzheimers Dement (2012) 1.01
Effects of carpal tunnel syndrome on adaptation of multi-digit forces to object weight for whole-hand manipulation. PLoS One (2011) 1.00
The impact of obesity on breast cancer: a retrospective review. Ann Surg Oncol (2012) 0.97
Neoadjuvant chemoradiation compared to neoadjuvant radiation alone and surgery alone for Stage II and III soft tissue sarcoma of the extremities. Radiat Oncol (2011) 0.97
The ghost in our genes: legal and ethical implications of epigenetics. Health Matrix Clevel (2009) 0.97
Cytokeratin-19 and mammaglobin gene expression in circulating tumor cells from metastatic breast cancer patients enrolled in North Central Cancer Treatment Group trials, N0234/336/436/437. Clin Cancer Res (2011) 0.95
The impact of concomitant medication use on patient eligibility for phase I cancer clinical trials. J Cancer (2012) 0.94
Breast medical oncologists' use of standard prognostic factors to predict a 21-gene recurrence score. Oncologist (2011) 0.94
Metastasectomy and surgical resection of the primary tumor in patients with stage IV breast cancer: time for a second look? Ann Surg Oncol (2010) 0.92
Cancer with diabetes: prevalence, metabolic control, and survival in an academic oncology practice. Endocr Pract (2012) 0.87
Risk factors associated with local and in-transit recurrence of cutaneous melanoma. Am J Surg (2010) 0.87
Screening for Muir-Torre syndrome using mismatch repair protein immunohistochemistry of sebaceous neoplasms. J Genet Couns (2012) 0.87
Reduced toxicity conditioning and allogeneic stem cell transplantation in adults using fludarabine, carmustine, melphalan, and antithymocyte globulin: outcomes depend on disease risk index but not age, comorbidity score, donor type, or human leukocyte antigen mismatch. Biol Blood Marrow Transplant (2013) 0.86
Phase Ib/II trial of CYKLONE (cyclophosphamide, carfilzomib, thalidomide and dexamethasone) for newly diagnosed myeloma. Br J Haematol (2015) 0.85
A significant number of women present with palpable breast cancer even with a normal mammogram within 1 year. Am J Surg (2010) 0.85
The Mayo Clinic manuscript series relative to the discussion, dissemination, and operationalization of the Food and Drug Administration guidance on patient-reported outcomes. Value Health (2007) 0.85
Developing a reproductive life plan. J Midwifery Womens Health (2011) 0.84
Expression profiling of formalin-fixed paraffin-embedded primary breast tumors using cancer-specific and whole genome gene panels on the DASL® platform. BMC Med Genomics (2010) 0.84
Ethical implications of epigenetics research. Nat Rev Genet (2009) 0.84
Effects of carpal tunnel syndrome on adaptation of multi-digit forces to object mass distribution for whole-hand manipulation. J Neuroeng Rehabil (2012) 0.84
Editors' overview: forbidding science? Sci Eng Ethics (2009) 0.84
Anxiety affects cognition differently in healthy apolipoprotein E ε4 homozygotes and non-carriers. J Neuropsychiatry Clin Neurosci (2011) 0.83
RC0639: phase II study of paclitaxel, trastuzumab, and lapatinib as adjuvant therapy for early stage HER2-positive breast cancer. Breast Cancer Res Treat (2013) 0.83
Effect of body mass index on tumor characteristics and disease-free survival in patients from the HER2-positive adjuvant trastuzumab trial N9831. Cancer (2013) 0.82
North central cancer treatment group (NCCTG) N0537: phase II trial of VEGF-trap in patients with metastatic breast cancer previously treated with an anthracycline and/or a taxane. Clin Breast Cancer (2012) 0.82
Effects of carpal tunnel syndrome on dexterous manipulation are grip type-dependent. PLoS One (2013) 0.81
Does magnetic resonance imaging accurately predict residual disease in breast cancer? Am J Surg (2009) 0.80
Regulatory and reimbursement innovation. Sci Transl Med (2013) 0.79
Scientific Presentation Award: The impact of magnetic resonance imaging on surgical treatment of invasive breast cancer. Am J Surg (2009) 0.79
The value of multigene predictors of clinical outcome in breast cancer: an analysis of the evidence. Expert Rev Mol Diagn (2014) 0.78
Preoperative predictors of nipple-areola complex involvement for patients undergoing mastectomy for breast cancer. Ann Surg Oncol (2011) 0.78
Laparoscopic radical nephrectomy for very large renal tumors (> or =10 cm): is there a size limit? J Endourol (2009) 0.77
Osteoporosis prevention in prostate cancer patients receiving androgen ablation therapy: placebo-controlled double-blind study of estradiol and risedronate: N01C8. Support Care Cancer (2009) 0.76
APOE varepsilon2 and presymptomatic stage Alzheimer disease: how much is not enough? Neurology (2010) 0.75
A promising approach for treatment of tumor-induced bone diseases: utilizing bisphosphonate derivatives of nucleoside antimetabolites. Bone (2010) 0.75
COEXISTING PROSTATE CANCER AND DIABETES MELLITUS: IMPLICATIONS FOR PATIENT OUTCOMES AND CARE. Endocr Pract (2017) 0.75
Determination of mild, moderate, and severe pain interference in patients with cancer. Pain (2017) 0.75
The impact of biopsy technique on upstaging, residual disease, and outcome in cutaneous melanoma. Am J Surg (2011) 0.75
Risk Factors Predicting Positive Margins at Primary Wide Local Excision of Cutaneous Melanoma. Dermatol Surg (2016) 0.75
Pancreatitis in Patients With Pancreas Divisum. Pancreas (2017) 0.75
Genetic samples and genetic philanthropy. Virtual Mentor (2004) 0.75